Teva Pharmaceutical Industries Ltd
TEVA.N- Latest Trade
- trading higher7.39USD
- 0
- 0.00%
- As of Jun 9 2023. Values delayed up to 15 minutes
- Today's Range
- -- - --
- 52 Week Range
- 6.78 - 11.45
- Previous Close
- 7.39
- Open
- 0.00
- Volume
- 0.00
- 3 Month Average Trading Volume
- 37.30
- Shares Out (Mil)
- 1,120.37
- Market Cap
- 30,944.69
- Forward P/E
- 3.24
- Dividend Yield
- 0.00
Key Statistics
3.00 mean rating - 15 analysts
- P/E Excl. Extra Items (TTM)
- 0.00
- Price To Sales (TTM)
- 0.57
- Price To Book (Quarterly)
- 1.08
- Price To Cash Flow (Per Share TTM)
- 0.00
- Total Debt/Total Equity (Quarterly)
- 263.21
- Long Term Debt/Equity (Quarterly)
- 250.20
- Return On Investment (TTM)
- -5.07
- Return On Equity (TTM)
- -3.75
2021 (millions USD)
About Teva Pharmaceutical Industries Ltd (TEVA.N)
Company Information
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Address
5 Bazel St, P O B 3190PETAH TIKVA,
49131
Israel
Industry
Biotechnology & Drugs
Executive Leadership
- Sol J. Barer
- Independent Chairman of the Board
- Richard D. Francis
- President, Chief Executive Officer
- Eliyahu Sharon Kalif
- Chief Financial Officer, Executive Vice President
- Galia Inbar
- Chief Human Resource Officer and Corporate Affairs, Executive Vice President
- Richard Daniell
- Executive Vice President - European Commercial
- Sven Dethlefs
- Executive Vice President - North America Commercial
- Eric Drape
- Executive Vice President - Global Operations
- Eric A. Hughes
- Executive Vice President, Global R & D, Chief Medical Officer
- Mark Sabag
- Executive Vice President - International Markets Commercial
- Eli Shani
- Executive Vice President - Global Marketing and Portfolio
- David Matthew Stark
- Executive Vice President, Chief Legal Officer
- Rosemary A. Crane
- Independent Director
- Amir Elstein
- Independent Director
- Gerald M. Lieberman
- Independent Director
- Roberto A. Mignone
- Independent Director
- Perry D. Nisen
- Independent Director
- Nechemia Jacob Peres
- Independent Director
- Ronit Satchi - Fainaro
- Independent Director
- Janet S. Vergis
- Independent Director
- Tal Zvi Zaks
- Independent Director
Latest News
Financials
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,961.80 | 0.09% |
| Copper | 728.00 | 0.41% |
| Brent Crude Oil | 76.17 | 0.28% |
| CBOT Soybeans | 1,376.00 | 0.94% |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 4,316.83 | 0.53% |
| Euro STOXX 50 | 4,295.92 | 0.04% |
| FTSE 100 | 7,564.29 | 0.47% |
| Nikkei 225 | 32,265.17 | 1.97% |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes